<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yannoutsos A</submitter><funding>Institut National Du Cancer</funding><pagination>212</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6743149</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>19(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Smoking is a strong risk factor for cancer and atherosclerosis. Cancer mortality, especially from lung cancer, overtakes cardiovascular (CV) death rate in patients with peripheral arterial disease (PAD). Only a few patients with lung cancer after PAD management may benefit from surgical excision. Circulating tumor cells (CTC) associated with low-dose chest CT (LDCT) may improve early cancer detection. This study focuses on a screening strategy that can address not only lung cancer but all tobacco-related cancers in this high-risk population.&lt;h4>Methods&lt;/h4>DETECTOR Project is a prospective cohort study in two French University hospitals. Participants are smokers or former smokers (≥30 pack-years, quitted ≤15 years), aged ≥55 to 80 years, with atherosclerotic PAD or abdom</pubmed_abstract><journal>BMC cardiovascular disorders</journal><pubmed_title>Peripheral arterial disease and systematic detection of circulating tumor cells: rationale and design of the DETECTOR prospective cohort study.</pubmed_title><pmcid>PMC6743149</pmcid><funding_grant_id>2016-085</funding_grant_id><pubmed_authors>Sanson H</pubmed_authors><pubmed_authors>Emmerich J</pubmed_authors><pubmed_authors>Chatellier G</pubmed_authors><pubmed_authors>Labrousse C</pubmed_authors><pubmed_authors>Tredaniel J</pubmed_authors><pubmed_authors>Zins M</pubmed_authors><pubmed_authors>Galloula A</pubmed_authors><pubmed_authors>Beaussier H</pubmed_authors><pubmed_authors>Duchatelle V</pubmed_authors><pubmed_authors>Lajonchere JP</pubmed_authors><pubmed_authors>Nasr NB</pubmed_authors><pubmed_authors>Lazareth I</pubmed_authors><pubmed_authors>Ghaffari P</pubmed_authors><pubmed_authors>Pastre J</pubmed_authors><pubmed_authors>Messas E</pubmed_authors><pubmed_authors>Damotte D</pubmed_authors><pubmed_authors>Yannoutsos A</pubmed_authors><pubmed_authors>Meyer G</pubmed_authors><pubmed_authors>Marini V</pubmed_authors><pubmed_authors>Fontaine M</pubmed_authors><pubmed_authors>Priollet P</pubmed_authors><pubmed_authors>Salmeron S</pubmed_authors><pubmed_authors>Paterlini-Brechot P</pubmed_authors><pubmed_authors>Schwering KL</pubmed_authors><pubmed_authors>Stansal A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Peripheral arterial disease and systematic detection of circulating tumor cells: rationale and design of the DETECTOR prospective cohort study.</name><description>&lt;h4>Background&lt;/h4>Smoking is a strong risk factor for cancer and atherosclerosis. Cancer mortality, especially from lung cancer, overtakes cardiovascular (CV) death rate in patients with peripheral arterial disease (PAD). Only a few patients with lung cancer after PAD management may benefit from surgical excision. Circulating tumor cells (CTC) associated with low-dose chest CT (LDCT) may improve early cancer detection. This study focuses on a screening strategy that can address not only lung cancer but all tobacco-related cancers in this high-risk population.&lt;h4>Methods&lt;/h4>DETECTOR Project is a prospective cohort study in two French University hospitals. Participants are smokers or former smokers (≥30 pack-years, quitted ≤15 years), aged ≥55 to 80 years, with atherosclerotic PAD or abdom</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Sep</publication><modification>2025-04-05T10:14:14.448Z</modification><creation>2019-09-24T07:11:15Z</creation></dates><accession>S-EPMC6743149</accession><cross_references><pubmed>31519196</pubmed><doi>10.1186/s12872-019-1193-1</doi></cross_references></HashMap>